Zacks Small Cap Analysis – IMNN: First Website Activated for Section 3 OVATION 3 Trial… – Model Slux
By David Bautz, PhD NASDAQ:IMNN READ THE FULL IMNN RESEARCH REPORT Enterprise Replace First Website Activated for Section 3 OVATION 3 Trial of IMNN-001 in Ovarian Most cancers On Might 8, 2025, Imunon, Inc. (NASDAQ:IMNN) introduced that the primary trial web site for the Section 3 OVATION 3 trial has been activated and is able … Read more
